Cytori Extends Distribution Agreement with GE Healthcare; Key Focus on Research Market
Cytori Therapeutics, Inc. (NASDAQ:CYTX) has extended the term and modified the focus of its current distribution agreeme…
Cytori Therapeutics, Inc. (NASDAQ:CYTX) has extended the term and modified the focus of its current distribution agreeme…
Cytori Therapeutics (Nasdaq:CYTX) reports second quarter and first half 2010 financial results. Further details, includi…
Cytori Therapeutics (NASDAQ: CYTX) has sold its first StemSource(R) Cell Bank in the United States. The StemSource(R) Ce…
Cytori Therapeutics (NASDAQ: CYTX) received an order for a StemSource(R) Cell Bank from Cosmetic Surgery Seishin in Japa…
Cytori Therapeutics (NASDAQ: CYTX) received two Notices of Allowance from the U.S. Patent & Trademark Office for patents…